Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Clinical trial NCT04910295 · COMPLETED
Trial details
- NCT number
- NCT04910295
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-26
- Primary completion
- 2022-04-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.